Laevogo Pflaumenaroma

Lactulose, the active ingredient in Laevogo Pflaumenaroma, is an osmotic laxative presented as a liquid oral solution for oral use. It treats constipation and hepatic encephalopathy in adults and children as directed by a healthcare professional.

GNH USA supplies Laevogo Pflaumenaroma as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lactulose is used to manage conditions related to bowel motility and hepatic ammonia accumulation.

- Constipation: softens stools and promotes regular bowel movements. - Hepatic encephalopathy: lowers blood ammonia by acidifying colonic contents, helping prevent neuropsychiatric episodes. - Colonoscopy preparation: assists in clearing the colon to improve endoscopic visualization.

Lactulose may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal cramping or discomfort - Flatulence or increased gas - Diarrhea or loose stools - Nausea or mild vomiting - Bloating or a feeling of fullness - Thirst or mild dehydration

Serious or Rare Side Effects: - Severe electrolyte imbalance (e.g., hyponatremia, hypokalemia) - Marked dehydration requiring medical attention - Allergic reactions such as rash, itching, or swelling - Acute hepatic decompensation in patients with advanced liver disease - Persistent watery diarrhea leading to fecal incontinence

Before initiating therapy, consider patient‑specific factors and monitor for complications. - Renal function: assess in patients with renal impairment, as reduced clearance may increase osmotic load. - Electrolytes: monitor serum electrolytes, especially potassium and sodium, during prolonged use. - Diabetes: observe blood glucose, as lactulose fermentation can affect glycemic control. - Intestinal obstruction: avoid use in known or suspected mechanical blockage. - Pediatric dosing: adjust dose carefully in children under medical supervision. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Lactulose can interact with other agents that affect gastrointestinal function or electrolyte balance.

Major Interactions (Avoid): - Antibiotics (e.g., quinolones): may reduce lactulose efficacy by altering gut flora. - Other laxatives (e.g., senna, bisacodyl): increase risk of excessive diarrhea and dehydration. - Loop or thiazide diuretics: may exacerbate electrolyte loss.

Moderate Interactions (Monitor Closely): - Antacids: can modify colonic pH, potentially affecting lactulose activity. - Probiotic supplements: may increase gas production and abdominal discomfort. - Oral hypoglycemic agents: monitor blood glucose as lactulose may influence carbohydrate absorption.